Status:
COMPLETED
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis
Lead Sponsor:
Novartis
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18+ years
Brief Summary
This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Consenting patients who participated in the core clinical trial
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00098150
Start Date
July 1 2004
Last Update
August 31 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.